P135 - Analogues de la somatostatine en premiere intention dans les adenomes somatotropes : traitement NEO-adjuvant ou traitement suffisant ? Impact d’une chirurgie de reduction tumorale ?
Nicolas Chevalier(Inserm), Jean‐Louis Sadoul(Centre Hospitalier Universitaire de Nice), S. Hiéronimus(Université Toulouse III - Paul Sabatier), A. Fredenrich(Centre Hospitalier Universitaire de Nice), S. Litrico(Centre Hospitalier Universitaire de Nice), B Canivet(Centre Hospitalier Universitaire de Nice), P. Paquis(Centre Hospitalier Universitaire de Nice), Patrick Fénichel(Inserm)
Cited by 0
Related Papers
Human Health and Ocean Pollution
|Annals of Global Health|2020|751
The Minderoo-Monaco Commission on Plastics and Human Health
|Annals of Global Health|2023|423
Bisphenol A: An endocrine and metabolic disruptor
|Annales d Endocrinologie|2013|278
Phenotypical, Biological, and Molecular Heterogeneity of 5α-Reductase Deficiency: An Extensive International Experience of 55 Patients
|The Journal of Clinical Endocrinology & Metabolism|2010|213
Obesity II: Establishing causal links between chemical exposures and obesity
|Biochemical Pharmacology|2022|197